Novel anti-platelet agents: focus on thrombin receptor antagonists.
about
Advances in induced pluripotent stem cells, genomics, biomarkers, and antiplatelet therapy highlights of the year in JCTR 2013.Eryptosis as a marker of Parkinson's diseasePlatelets and autoimmunity.Vein graft failure: from pathophysiology to clinical outcomes.Efficacy and safety of vorapaxar for the prevention of adverse cardiac events in patients with coronary artery disease: a meta-analysis.Dental management of patients on anti-thrombotic agents
P2860
Novel anti-platelet agents: focus on thrombin receptor antagonists.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel anti-platelet agents: focus on thrombin receptor antagonists.
@en
type
label
Novel anti-platelet agents: focus on thrombin receptor antagonists.
@en
prefLabel
Novel anti-platelet agents: focus on thrombin receptor antagonists.
@en
P2860
P1476
Novel anti-platelet agents: focus on thrombin receptor antagonists.
@en
P2093
Flavio de Souza Brito
P2860
P2888
P304
P356
10.1007/S12265-013-9454-3
P407
P577
2013-02-22T00:00:00Z
P5875
P6179
1016999795